Oral Decontamination with Chlorhexidine Reduces the Incidence of Ventilator-associated Pneumonia
Mirelle Koeman,
Andre J. A. M. van der Ven,
Eelko Hak,
Hans C. A. Joore,
Karin Kaasjager,
Annemarie G. A. de Smet,
Graham Ramsay,
Tom P. J. Dormans,
Leon P. H. J. Aarts,
Ernst E. de Bel,
Willem N. M. Hustinx,
Ingeborg van der Tweel,
Andy M. Hoepelman and
Marc J. M. Bonten
Division of Medicine, Infectious Diseases, and Geriatrics, Department of Internal Medicine and Dermatology; Julius Center for Health Sciences and Primary Care; Department of Perioperative Care and Emergency Medicine; Center for Biostatistics; Eijkman Winkler Institute for Microbiology, Inflammation, and Infectious Diseases, University Medical Centre Utrecht; Department of Intensive Care Medicine, Diakonessenhuis Utrecht, Utrecht; Department of Infectious Diseases, University Medical Centre Nijmegen, Nijmegen; Department of Internal Medicine and Intensive Care Medicine, Rijnstate Hospital Arnhem, Arnhem; Hospital Board, Atrium Medical Center; Department of Intensive Care Medicine, Atrium Hospital Heerlen, Heerlen; and Department of Anesthesiology and Intensive Care Medicine, Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands
Correspondence and requests for reprints should be addressed to Mirelle Koeman, M.D., University Medical Center Utrecht, Department of Emergency Medicine and Infectious Diseases (F02.126), Heidelberglaan 100, 3884CX Utrecht, The Netherlands. E-mail: groenendijk-koeman{at}wanadoo.nl
Rationale: Ventilator-associated pneumonia (VAP) is the mostfrequently occurring nosocomial infection associated with increasedmorbidity and mortality. Although oral decontamination withantibiotics reduces incidences of VAP, it is not recommendedbecause of potential selection of antibiotic-resistant pathogens.We hypothesized that oral decontamination with either chlorhexidine(CHX, 2%) or CHX/colistin (CHX/COL, 2%/2%) would reduce andpostpone development of VAP, and oral and endotracheal colonization.
Objectives: To determine the effect of oral decontaminationwith CHX or CHX/COL on VAP incidence and time to developmentof VAP.
Methods: Consecutive patients needing mechanical ventilationfor 48 h or more were enrolled in a randomized, double-blind,placebo-controlled trial with three arms: CHX, CHX/COL, andplacebo (PLAC). Trial medication was applied every 6 h intothe buccal cavity. Oropharyngeal swabs were obtained daily andquantitatively analyzed for gram-positive and gram-negativemicroorganisms. Endotracheal colonization was monitored twiceweekly.
Results: Of 385 patients included, 130 received PLAC, 127 CHXand 128 CHX/COL. Baseline characteristics were comparable. Thedaily risk of VAP was reduced in both treatment groups comparedwith PLAC: 65% (hazard ratio [HR] = 0.352; 95% confidence interval[CI], 0.160, 0. 791; p = 0.012) for CHX and 55% (HR = 0.454;95% CI, 0.224, 0. 925; p = 0.030) for CHX/COL. CHX/COL providedsignificant reduction in oropharyngeal colonization with bothgram-negative and gram-positive microorganisms, whereas CHXmostly affected gram-positive microorganisms. Endotracheal colonizationwas reduced for CHX/COL patients and to a lesser extent forCHX patients. No differences in duration of mechanical ventilation,intensive care unit stay, or intensive care unit survival couldbe demonstrated.
Conclusions: Topical oral decontamination with CHX or CHX/COLreduces the incidence of VAP.
B. Afessa, A. F. Shorr, A. R. Anzueto, D. E. Craven, R. Schinner, and M. H. Kollef Association Between a Silver-Coated Endotracheal Tube and Reduced Mortality in Patients With Ventilator-Associated Pneumonia
Chest,
May 1, 2010;
137(5):
1015 - 1021.
[Abstract][Full Text][PDF]
A. Torres and J. Rello Update in Community-acquired and Nosocomial Pneumonia 2009
Am. J. Respir. Crit. Care Med.,
April 15, 2010;
181(8):
782 - 787.
[Full Text][PDF]
L. L. Feider, P. Mitchell, and E. Bridges Oral Care Practices for Orally Intubated Critically Ill Adults
Am. J. Crit. Care.,
March 1, 2010;
19(2):
175 - 183.
[Abstract][Full Text][PDF]
S. T. Micek and L. P. Skrupky Current Concepts in the Prevention and Treatment of Ventilator-Associated Pneumonia
Journal of Pharmacy Practice,
February 1, 2010;
23(1):
25 - 32.
[Abstract][Full Text][PDF]
C. D. Hingston, J. M. Cole, E. J. Hingston, P. J. Frost, and M. P. Wise Oral Hygiene and Nosocomial Pneumonia in Critically III Patients
Chest,
January 1, 2010;
137(1):
237 - 238.
[Full Text][PDF]
T. S. Panchabhai, N. S. Dangayach, A. Krishnan, V. M. Kothari, and D. R. Karnad Response
Chest,
January 1, 2010;
137(1):
238 - 238.
[Full Text][PDF]
R. Garcia, L. Jendresky, L. Colbert, A. Bailey, M. Zaman, and M. Majumder Reducing Ventilator-Associated Pneumonia Through Advanced Oral-Dental Care: A 48-Month Study
Am. J. Crit. Care.,
November 1, 2009;
18(6):
523 - 532.
[Abstract][Full Text][PDF]
A. Gacouin, N. Barbarot, C. Camus, S. Salomon, S. Isslame, S. Marque, S. Lavoue, P.-Y. Donnio, R. Thomas, and Y. Le Tulzo Late-Onset Ventilator-Associated Pneumonia in Nontrauma Intensive Care Unit Patients
Anesth. Analg.,
November 1, 2009;
109(5):
1584 - 1590.
[Abstract][Full Text][PDF]
C. L. Munro, M. J. Grap, D. J. Jones, D. K. McClish, and C. N. Sessler Chlorhexidine, Toothbrushing, and Preventing Ventilator-Associated Pneumonia in Critically Ill Adults
Am. J. Crit. Care.,
September 1, 2009;
18(5):
428 - 437.
[Abstract][Full Text][PDF]
A. Pobo, T. Lisboa, A. Rodriguez, R. Sole, M. Magret, S. Trefler, F. Gomez, J. Rello, and for the RASPALL Study Investigators A Randomized Trial of Dental Brushing for Preventing Ventilator-Associated Pneumonia
Chest,
August 1, 2009;
136(2):
433 - 439.
[Abstract][Full Text][PDF]
M. L.G. Pedreira, D. M. Kusahara, W. B. de Carvalho, S. C. Nunez, and M. A. S. Peterlini Oral Care Interventions and Oropharyngeal Colonization in Children Receiving Mechanical Ventilation
Am. J. Crit. Care.,
July 1, 2009;
18(4):
319 - 328.
[Abstract][Full Text][PDF]
M. A. Halm and R. Armola Effect of Oral Care on Bacterial Colonization and Ventilator-Associated Pneumonia
Am. J. Crit. Care.,
May 1, 2009;
18(3):
275 - 278.
[Full Text][PDF]
J. Dallas and M. Kollef Oral Decontamination to Prevent Ventilator-Associated Pneumonia: Is It a Sound Strategy?
Chest,
May 1, 2009;
135(5):
1116 - 1118.
[Full Text][PDF]
T. S. Panchabhai, N. S. Dangayach, A. Krishnan, V. M. Kothari, and D. R. Karnad Oropharyngeal Cleansing With 0.2% Chlorhexidine for Prevention of Nosocomial Pneumonia in Critically Ill Patients: An Open-Label Randomized Trial With 0.01% Potassium Permanganate as Control
Chest,
May 1, 2009;
135(5):
1150 - 1156.
[Abstract][Full Text][PDF]
C. S. Sona, J. E. Zack, M. E. Schallom, M. McSweeney, K. McMullen, J. Thomas, C. M. Coopersmith, W. A. Boyle, T. G. Buchman, J. E. Mazuski, et al. The Impact of a Simple, Low-cost Oral Care Protocol on Ventilator-associated Pneumonia Rates in a Surgical Intensive Care Unit
J Intensive Care Med,
January 1, 2009;
24(1):
54 - 62.
[Abstract][PDF]
M. H. Kollef, B. Afessa, A. Anzueto, C. Veremakis, K. M. Kerr, B. D. Margolis, D. E. Craven, P. R. Roberts, A. C. Arroliga, R. D. Hubmayr, et al. Silver-Coated Endotracheal Tubes and Incidence of Ventilator-Associated Pneumonia: The NASCENT Randomized Trial
JAMA,
August 20, 2008;
300(7):
805 - 813.
[Abstract][Full Text][PDF]
J. Chastre Preventing Ventilator-Associated Pneumonia: Could Silver-Coated Endotracheal Tubes Be the Answer?
JAMA,
August 20, 2008;
300(7):
842 - 844.
[Full Text][PDF]
S. Nseir From the authors
Eur. Respir. J.,
January 1, 2008;
31(1):
221 - 222.
[Full Text][PDF]
L. Lorente, S. Blot, and J. Rello Evidence on measures for the prevention of ventilator-associated pneumonia
Eur. Respir. J.,
December 1, 2007;
30(6):
1193 - 1207.
[Abstract][Full Text][PDF]
A. P. Wheeler Recent Developments in the Diagnosis and Management of Severe Sepsis
Chest,
December 1, 2007;
132(6):
1967 - 1976.
[Abstract][Full Text][PDF]
P. K. Kutty, B. Moody, J. S. Gullion, M. Zervos, M. Ajluni, R. Washburn, R. Sanderson, M. A. Kainer, T. A. Powell, C. F. Clarke, et al. Multistate Outbreak of Burkholderia cenocepacia Colonization and Infection Associated With the Use of Intrinsically Contaminated Alcohol-Free Mouthwash
Chest,
December 1, 2007;
132(6):
1825 - 1831.
[Abstract][Full Text][PDF]
A. M. Berry, P. M. Davidson, J. Masters, and K. Rolls Systematic Literature Review of Oral Hygiene Practices for Intensive Care Patients Receiving Mechanical Ventilation
Am. J. Crit. Care.,
November 1, 2007;
16(6):
552 - 562.
[Abstract][Full Text][PDF]
H. van Saene, J. van Saene, L. Silvestri, M. de la Cal, R. Sarginson, and D. Zandstra Iseganan Failure Due to the Wrong Pharmaceutical Technology
Chest,
October 1, 2007;
132(4):
1412 - 1412.
[Full Text][PDF]
E. B. Milbrandt, A. Ishizaka, and D. C. Angus Update in Critical Care 2006
Am. J. Respir. Crit. Care Med.,
April 1, 2007;
175(7):
638 - 648.
[Full Text][PDF]
H. Kishimoto and M. Urade Mechanical Tooth Cleaning before Chlorhexidine Application
Am. J. Respir. Crit. Care Med.,
February 15, 2007;
175(4):
418a - 418a.
[Full Text][PDF]
E. Y. Chan Oral decontamination with chlorhexidine reduced ventilator associated pneumonia in patients needing mechanical ventilation for >=48 hours
Evid. Based Nurs.,
January 1, 2007;
10(1):
19 - 19.
[Full Text][PDF]
ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB
Evid. Based Med.,
December 1, 2006;
11(6):
190 - 190.
[Full Text][PDF]
D. E. Craven Preventing ventilator-associated pneumonia in adults: sowing seeds of change.
Chest,
July 1, 2006;
130(1):
251 - 260.
[Abstract][Full Text][PDF]
D. E. Craven and R. A. Duncan Preventing Ventilator-associated Pneumonia: Tiptoeing through a Minefield.
Am. J. Respir. Crit. Care Med.,
June 15, 2006;
173(12):
1297 - 1298.
[Full Text][PDF]